Cell Signaling Technology, Inc.
Danvers, MA Doing business as Cell Signaling Technology Inc.
- UEI
- DEUMJK7A3NH4
- CAGE
- 3LTH3
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3 Trask Ln, Danvers, MA 01923, USA
- Website
- cellsignal.com
- Founded
- 1999
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nida lab requires antibodies in order to support ongoing experiments | National Institute on Drug Abuse | $24,873 | |
| Ambis 2261414- cell technologies: antibodies and reagents for WB analysis | National Institute of Allergy and Infectious Diseases | $13,220 | |
| To conduct global TMT profiling analysis service | National Heart Lung and Blood Institute | $52,000 | |
| Proteome analysis services | National Heart Lung and Blood Institute | $224,000 | |
| Ubscan standard service | National Cancer Institute | $20,000 |
About Cell Signaling Technology, Inc.
Cell Signaling Technology, Inc. is a private, family-owned company based in Danvers, Massachusetts, that specializes in developing and producing advanced scientific research products, particularly antibodies, kits, and reagents used to study cell signaling pathways. Registered in SAM.gov since 2003, the company is structured as a for-profit corporate entity and a manufacturer of goods, with a primary focus on applied systems biology research related to cancer and biomedical sciences. The company has demonstrated a strong capability in providing specialized scientific services to various federal agencies, primarily within the National Institutes of Health (NIH) ecosystem.
The federal contract awards reveal that Cell Signaling Technology, Inc. provides sophisticated scientific research services across multiple federal agencies, predominantly within the NIH network. These services include proteome analysis, mass spectrometry, tandem mass tag (TMT) profiling, and specialized antibody and reagent procurement for advanced scientific experiments. Specific contract awards include a $224,000 proteome analysis service for the National Heart, Lung and Blood Institute, a $52,000 global TMT profiling analysis for the National Human Genome Research Institute, and multiple purchase orders for antibodies and research materials from agencies like the National Institute on Drug Abuse (NIDA) and the National Institute of Allergy and Infectious Diseases (NIAID). None of these contracts utilized set-aside designations, indicating the company competes on an unrestricted basis. The contract values range from approximately $13,000 to $224,000, with performance periods typically spanning several months to a year, and focus primarily on supporting advanced biomedical and cancer-related research initiatives.
Quick answers
What is Cell Signaling Technology, Inc.'s UEI?
Cell Signaling Technology, Inc.'s Unique Entity ID (UEI) in SAM.gov is DEUMJK7A3NH4.
What is Cell Signaling Technology, Inc.'s CAGE code?
Cell Signaling Technology, Inc.'s CAGE code is 3LTH3.
What is Cell Signaling Technology, Inc.'s primary NAICS code?
Cell Signaling Technology, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Cell Signaling Technology, Inc. located?
Cell Signaling Technology, Inc.'s physical address in SAM.gov is 3 Trask Ln, Danvers, MA 01923, USA.
Is Cell Signaling Technology, Inc. registered in SAM.gov?
Yes. Cell Signaling Technology, Inc.'s SAM.gov registration is active through November 20, 2026.
What is Cell Signaling Technology, Inc.'s most recent federal award?
Cell Signaling Technology, Inc.'s most recent federal contract award is Nida lab requires antibodies in order to support ongoing experiments (75N95025P00391), from National Institute on Drug Abuse, on September 9, 2025.
On GovTribe
See Cell Signaling Technology, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors